Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
MediciNova completed the last patient, last visit in the double-blind portion of its Phase 2b/3 COMBAT-ALS trial of MN-166 and expects topline results by end-2026. Full study LPLV is expected in March 2027.Material DetailsContext by AI AnalystThis is a late-stage operational milestone that confirms…
MediciNova completed the last patient, last visit in the double-blind portion of its COMBAT-ALS Phase 2b/3 trial of MN-166. Topline results have not been presented yet; release is expected by end-2026, with the full study’s final visit expected in March 2027. The update keeps the program on track for data lock and anal